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Purpose: The Mycobacterium tuberculosis complex comprises M. tuberculosis, 
M. bovis, M. bovis bacillus Calmette-Guérin (BCG) and M. africanum, and causes 
tuberculosis in humans and animals. Identification of Mycobacterium spp. and M. 
tuberculosis complex to the species level is important for practical use in microbi-
ological laboratories, in addition to optimal treatment and public health. Materials 
and Methods: A novel multiplex PCR assay targeting a conserved rpoB sequence 
in Mycobacteria spp., as well as regions of difference (RD) 1 and RD8, was devel-
oped and evaluated using 37 reference strains and 178 clinical isolates. Results: 
All mycobacterial strains produced a 518-bp product (rpoB), while other bacteria 
produced no product. Virulent M. tuberculosis complex strains, M. tuberculosis, 
M. bovis and M. africanum, produced a 254-bp product (RD1), while M. bovis 
BCG, M. microti and nontuberculous mycobacteria produced no RD1 region 
product. Additionally, M. tuberculosis and M. africanum produced a 150-bp prod-
uct (RD8), while M. bovis and M. bovis BCG produced a 360-bp product (deleted 
form of RD8). M. microti and nontuberculous mycobacteria produced no RD8 re-
gion product. This assay identified all Mycobacterium spp. and all M. tuberculosis 
complex strains to the species level. Conclusion: The multiplex PCR assay of the 
present study could be implemented as a routine test in microbiology laboratories, 
and may contribute to more effective treatment and surveillance of tuberculosis 
stemming from the M. tuberculosis complex.
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INTRODUCTION
Tuberculosis is a global health problem, with approximately 8.8 million new cases 
and 1.4 million deaths reported in 2010.1 The disease is caused by members of the 
Mycobacterium tuberculosis (M. tuberculosis) complex, a group of closely related 
species and subspecies, which include M. tuberculosis, M. africanum, M. bovis, M. 
bovis bacillus Calmette-Guérin (BCG), M. microti, M. canettii, M. pinnipedii, and 
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berculosis and M. bovis, but is absent in M. bovis BCG, al-
lowing for M. tuberculosis and M. bovis to be differentiated 
from M. bovis BCG.11,12 Additionally, a novel RD8 is pres-
ent in M. tuberculosis and M. africanum that is deleted in 
M. bovis and M. bovis BCG and absent in M. microti and 
nontuberculous mycobacteria.14
In this study, we developed a rapid and efficient multi-
plex PCR assay that enables not only the identification of 
the genus Mycobacterium using the rpoB sequence con-
served in all mycobacteria, but also the identification of the 
M. tuberculosis complex to the species level, using RD1 
and RD8 sequences. The assay was shown to be simple and 
efficient in identifying Mycobacterium genus and distin-
guishing the M. tuberculosis complex to the species level.
MATERIALS AND METHODS
　　　
Bacterial strains 
The bacterial strains used in this study are listed in Table 1. 
Seventy-six clinical M. tuberculosis isolates from humans 
and 52 clinical M. bovis isolates from cattle were provided 
kindly from Yonsei University College of Medicine, Seoul, 
Korea. Twenty-seven clinical M. avium isolates and 23 clini-
cal M. intracellulare isolates from humans were provided by 
the Korea Institute of Tuberculosis, Osong, Korea.  
Culture media and DNA extraction
Bacterial culture and chromosomal DNA isolation were 
performed as previously described.13 Briefly, bacteria were 
cultured on Middlebrook 7H9 media (Difco, Detroit, MI, 
USA) supplemented with 10% Middlebrook OADC En-
richment media (BBL, Sparks, MD, USA) at 37°C for 2 to 
4 weeks. Bacterial cells were collected by centrifugation at 
10000×g, resuspended in distilled water, and boiled for 10 
min. Cell debris was sedimented by centrifugation for 2 
min at 10000×g, and the resultant DNA concentration was 
measured using a spectrophotometer (260 nm, Amersham 
Pharmacia Biotech Inc., Piscataway, NJ, USA). DNA was 
stored at -20°C prior to use. 
PCR primer design
The primers used in this study are listed in Table 2. The ge-
nome sequence of M. tuberculosis H37Rv was imported 
into the Vector NTI® Software (Life technologies, Grand Is-
land, NY, USA), and rpoB, RD1 and RD8 were created ac-
cording to the genome address. Primers were selected by 
M. mungi.2 M. tuberculosis is the most common cause of 
tuberculosis in humans. M. bovis causes tuberculosis in hu-
mans and animals, and is responsible for 10 to 15% of new 
human tuberculosis cases in developing countries.3 M. bo-
vis BCG, a live attenuated strain of M. bovis, is a widely 
used anti-tuberculosis vaccine, and is used for the treatment 
of bladder cancer.4 However, M. bovis BCG is known to 
lead to complications, such as osteomyelitis, abscesses, 
lymphadenitis, and dissemination of M. bovis BCG, most 
severely in human immunodeficiency virus-infected neo-
nates and children. In M. bovis BCG-treated patients, com-
plications such as pneumonitis, hepatitis and noncaseating 
granulomas have been reported.5
Identification of the M. tuberculosis complex to the spe-
cies level is important for public health, epidemiology and 
treatment.6 In the laboratory, tuberculosis is diagnosed by 
acid-fast bacilli (Ziehl-Neelsen) staining and culturing of 
mycobacteria, followed by identification of the cultured 
mycobacteria. For more rapid identification, several poly-
merase chain reaction (PCR)-based methods have been de-
veloped, and PCR assay that targets M. tuberculosis-specific 
sequences, including IS6110 and the MPT64 gene, has been 
widely applied.7 However, while this assay can differentiate 
the M. tuberculosis complex from nontuberculous myco-
bacteria, it cannot identify the M. tuberculosis complex to 
the species level.7 For rapid and efficient identification of 
the M. tuberculosis complex, several PCR-based methods 
have been developed.8-10 However, these are rarely used as 
a routine test in diagnostic laboratories as they require two 
rounds of PCR reaction and electrophoresis to distinguish 
the M. tuberculosis complex from other mycobacteria and 
to identify M. tuberculosis complex to the species level.11,12 
Moreover, identification of nontuberculous mycobacteria to 
the species level is of greater importance due to the in-
creased incidence of infection with nontuberculous myco-
bacteria. Thus, more rapid and efficient methods of identifi-
cation are needed.
A well-validated probe for the Mycobacterium genus tar-
gets the conserved sequence of the rpoB gene, which en-
codes the β subunit of RNA polymerase, and not only facil-
itates identification of all Mycobacterium spp., but also 
distinguishes Mycobacterium spp. at the species level by 
restriction enzyme analysis.13 In a comparative genomics 
study of M. tuberculosis H37Rv, 16 regions of the genome 
(regions of difference, RD) were shown to be deleted in M. 
bovis and M. bovis BCG.10 One of them, RD1, is present in 
virulent M. tuberculosis complex strains, including M. tu-
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1.5 units of Taq DNA polymerase (Bioneer, Daejeon, Ko-
rea), and 20 ng of genomic DNA as the template. PCR am-
plification was performed in an automated thermal cycler 
(PTC-100 Programmable Thermal Controller, MJ Research, 
Inc., Waltham, MA, USA). The cycling parameters were 
94°C for 5 min, followed by 35 cycles of denaturation at 
94°C for 30 s, annealing at 68°C for 30 s and a final exten-
sion at 72°C for 7 min. Sterile distilled water was used as a 
negative control. Analysis of PCR products was performed 
by electrophoresis in ethidium bromide (0.5 µg/mL)-stained 
1.7 % (w/v) agarose gels.
 
RESULTS
 
Validation of the PCR method
PCR conditions were optimized with four sets of primer 
pairs using M. tuberculosis H37Rv, M. bovis AN5 and M. 
bovis BCG Pasteur as representative strains (Figs. 1 and 2), 
and confirmed using all bacterial strains by gel electropho-
resis. The PCR products for each target sequence from each 
set of primer pairs were also confirmed. All reference my-
cobacterial strains consistently yielded a single 518-bp 
product with primers rpoB-F and rpoB-R, but other bacteri-
al strains yielded no products, indicating that all mycobac-
terial strains contained the specific rpoB gene (Table 3). M. 
tuberculosis H37Rv, M. africanum and M. bovis AN5 con-
sistently yielded a single 254-bp product with RD1-F and 
RD1-R primers, but other bacterial strains, including all M. 
bovis BCG strains and M. microti, yielded no product with 
RD1-F and RD1-R primers, indicating the RD1 sequence is 
present in virulent M. tuberculosis complex strains. M. tu-
berculosis and M. africanum type strains consistently yield-
ed a single 150-bp product with RD8-F and RD8-T-R prim-
ers, but yielded no product with RD8-F and RD8-T-R 
primers, indicating the presence of the RD8 sequence. Con-
versely, M. bovis and all M. bovis BCG strains consistently 
yielded a single 360-bp product with RD8-F and RD8-B-R 
primers, but yielded no product with RD8-F and RD8-T-R 
primers, indicating a deletion of the RD8 sequence in M. 
bovis, including M. bovis BCG (Fig. 1, Table 3). However, 
other bacteria, including nontuberculous mycobacteria and 
M. microti, yielded no product with either RD8-F and RD8-
T-R or RD8-F and RD8-B-R primers. 
Multiplex PCR on reference strains and clinical isolates
PCR products using the four sets of primer pairs were per-
analysis of the appropriate genomic regions using Primer 3 
software (http://frodo.wi.mit.edu/) (Fig. 1, Table 2).  
 
PCR amplification
The amplification reaction mixture consisted of 10 mM Tri-
HCl, 50 mM KCl, 1.5 mM MgCl2, 200 µM of each primer, 
Table 1. Bacterial Strains Used in This Study
Species (no. of strains) Reference no./Source
M. tuberculosis H37Rv ATCC27294
M. tuberculosis Erdman ATCC35801
M. tuberculosis (76) YUMC
M. bovis AN5 ATCC35726
M. bovis (52) YUMC
M. bovis BCG Pasteur YUMC
M. bovis BCG Danish YUMC
M. bovis BCG Tokyo YUMC
M. bovis BCG Tice YUMC
M. abscessus ATCC19977
M. africanum ATCC25420
M. avium ATCC25291
M. avium ATCC35719
M. avium (27) KIT
M. celatum ATCC51130
M. celatum ATCC51131
M. chelonae ATCC19237
M. fortuitum ATCC49403
M. fortuitum ATCC49404
M. gilvum ATCC43909
M. gordonae ATCC14470
M. intracellulare ATCC13950
M. intracellulare (23) KIT
M. kansasii ATCC12478
M. marinum ATCC927
M. microtii ATCC19422
M. mucogenicum ATCC49649
M. peregrinum ATCC14467
M. senegalense ATCC35796
M. septicum ATCC700731
M. smegmatis ATCC19420
M. szulgai ATCC 35799
M. terrae ATCC15755
M. ulcerans ATCC19423
Enterococcus faecalis ATCC29212
E. faecium ATCC35667
Escherichia coli ATCC25922
Haemophilus infulenza ATCC49247
Micrococcus lutens ATCC49732
Pseudomonas aeroginosa ATCC27853
Staphylococcus aureus ATCC29213
YUMC, Yonsei University College of Medicine, Seoul, Korea; KIT, Korea 
Institute of Tuberculosis, Osong, Korea; BCG, bacillus Calmette-Guérin.
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results identical to M. tuberculosis (Fig. 3). However, multi-
plex PCR of M. microti yielded only a 518-bp product, simi-
lar to nontuberculous mycobacteria. 
Multiplex PCR on M. bovis AN5 and 52 clinical M. bovis 
isolates yielded 518-, 360- and 254-bp products, indicating 
the presence of rpoB and RD1, as well as the deletion of 
RD8 (Fig. 5). All four M. bovis BCG strains yielded 518- 
and 360-bp products, indicating the presence of rpoB, the 
formed on 30 reference strains and 178 clinical isolates 
(Figs. 3, 4 and 5). Multiplex PCR of M. tuberculosis H37Rv 
and M. tuberculosis Erdman yielded three 518-, 254- and 
150-bp products, indicating the presence of rpoB, RD1 and 
RD8, respectively (Fig. 4). Multiplex PCR of 76 clinical M. 
tuberculosis isolates provided results identical to the M. tu-
berculosis reference strain (Fig. 4). Multiplex PCR of M. af-
ricanum, a member of the M. tuberculosis complex, yielded 
Fig. 2. Multiplex PCR for M. tuberculosis, M. bovis and M. bovis bacillus Calmette-Guérin (BCG) strains. PCR products were separated by electrophoresis 
and visualized. Lanes M: molecular size marker (100-bp ladder); 1: M. bovis BCG Pasteur; 2: M. bovis BCG Tice; 3: M. bovis BCG Tokyo; 4: M. bovis AN5; 5: M. 
tuberculosis H37Rv; 6: negative control. Expected sizes of PCR products are shown. RD, regions of difference; PCR, polymerase chain reaction; ESAT-6, early 
secreted antigenic target 6 kDa protein.
500
300
200
100
rpoB (518 bp)
RD8 absent (518 bp)
ESAT-6 (254 bp)
RD8 present (150 bp)
bp                  M                1                 2                  3                   4                5                 6
Fig. 1. Schematic diagram showing regions flanking the direct repeat region in M. tuberculosis H37Rv, M. bovis and M. bovis bacillus Calmette-Guérin 
(BCG). This region is specifically deleted in M. bovis and M. bovis BCG, indicated by dotted lines. Primer positions are indicated by small arrows. RD, regions 
of difference.
M. tuberculosis & 
M. africanum
Region specifically deleted 
  in M. bovis and M. bovis BCG
M. bovis & BCG
Rv3616c ephA Rv3618 esxV esxW PPE65 PE32 IpqG hpt
Rv3616c lpqG hpt
(150 bp)
(360 bp)
(-6.3 Kb)
RD8
RD8
Table 2. Primers Used in This Study
Description of target Product length (bp) Primer names Primer sequences
rpoB 518
rpoB-F GCTGGACATCTACCGCAAGCTGC
rpoB-R CAGCGGGTTGTTCTGGTCCATG
RD1 (ESAT-6) 254
RD1-F CGAGGGGAAGCAGTCCCTGA
RD1-R AGGTCGAACTCGCCCGATCC
RD8 present 150
RD8-F GTCGAAGCGGGGCGCTCT
RD8-T-R GCGCAACGGATTTCCATCGT
RD8 deleted 360
RD8-F GTCGAAGCGGGGCGCTCT
RD8-B-R GGTTCTTGGCGTCTTGGAAGG
RD, regions of difference.
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DISCUSSION
We developed a simple and effective multiplex PCR assay 
that enabled the differentiation of Mycobacteria spp. from 
other bacteria and identified the M. tuberculosis complex to 
the species level. Our analysis using reference strains and 
clinical isolates suggested that the multiplex PCR assay is 
specific for M. tuberculosis, M. bovis and M. bovis BCG, as 
well as nontuberculosis mycobacteria. The conserved rpoB 
sequence of the mycobacteria was used to differentiate the 
genus Mycobacterium from other bacteria, resulting in data 
specific for all Mycobacteria spp. tested.13 Moreover, the 
fragment length polymorphism of the 518-bp PCR prod-
ucts targeting rpoB were effective for species identification 
(data not shown). This sequence offers advantages over oth-
er target sequences, including IS6110 and 16S RNA. IS6110 
can be used for the detection of M. tuberculosis complex, 
but cannot differentiate members of the M. tuberculosis 
complex.7 16S RNA has been used for the identification of 
Mycobacteria spp., but is unable to provide identification of 
absence of RD1 and the deletion of RD8. Multiplex PCR of 
23 nontuberculous mycobacteria reference strains and 50 
clinical nontuberculous mycobacteria isolates yielded only 
a 518-bp product, indicating the absence of RD1 and RD8. 
Multiplex PCR of other non-mycobacterial bacteria yielded 
no positive results. The data were consistently reproducible, 
and complete concordance between independent research-
ers was confirmed.
Fig. 3. Multiplex PCR for the Mycobacterium species. PCR products were separated by electrophoresis and visualized. Lanes M: molecular size marker (100-
bp ladder); 1: M. avium; 2: M. africanum; 3: M. abscesses; 4: M. celatum; 5: M. chelonae; 6: M. fortuitum; 7: M. gordonae; 8: M. intracellulare; 9: M. kansasii; 
10: M. marinum; 11: M. microtii; 12: M. phlei; 13: M. septicum; 14: M. szulgai; 15: M. terrae; 16: M. ulcerans; PCR, polymerase chain reaction.
Fig. 4. Multiplex PCR for clinical M. tuberculosis isolates. PCR products were separated by electrophoresis and visualized. Lanes M: molecular size marker 
(100-bp ladder); 1-15: M. tuberculosis isolates; 16: M. tuberculosis H37Rv; 17: M. tuberculosis Erdman; PCR, polymerase chain reaction.
500
300
200
100
bp                  M            1           2             3             4            5          6          7              8            9          10         11          12          13         14         15         16
500
300
200
100
bp             M           1         2             3          4           5           6            7          8          9           10          11        12         13          14          15        16        17
Table 3. Signature Patterns of Positive and Negative Multi-
plex PCR Used to Discriminate Mycobacterial Strains
Organism
PCR result for target
rpoB RD1
RD8 
present 
RD8 
deleted
M. tuberculosis + + + -
M. bovis + + - +
M. bovis BCG + - - +
M. africanum + + + -
M. microti + - - -
NTM + - - -
Other bacteria - - - -
RD, regions of difference; BCG, bacillus Calmette-Guérin; PCR, polymerase 
chain reaction; NTM, non-tuberculous Mycobacteria. 
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not used routinely in clinical microbiology laboratories as 
they are time consuming and costly. Recently, multiplex 
PCR assays have been proposed as a diagnostic method due 
to a single reaction and multiple targets.7,11,12 The present as-
say is the first multiplex PCR assay shown to identify the 
Mycobacterium genus and distinguish the M. tuberculosis 
complex to the species level by targeting the rpoB sequence, 
as well as RD1 and RD8 sequences, respectively.          
This assay can be used as a routine diagnostic test in mi-
crobiology laboratories and may contribute to determination 
of an optimal treatment regimen, improve the surveillance 
of tuberculous disease due to members of the M. tuberculo-
sis complex, and aid in the identification of the M. tubercu-
losis complex and nontuberculous mycobacteria.
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